{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:39:59Z","timestamp":1784241599426,"version":"3.55.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aimed to clarify whether lobectomy provides survival benefits for patients with early-stage medullary thyroid carcinoma (MTC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design, Setting, and Participants<\/jats:title>\n                  <jats:p>Patients with tumor size less than 4\u2009cm, excluding those with lateral neck involvement, bilateral foci, extrathyroidal extension, or distant metastases, were enrolled from the Surveillance, Epidemiology, and End Results (SEER) database and Zhejiang Cancer Hospital in China. Propensity score matching (PSM), Kaplan-Meier analysis, and Cox regression analyses were used to evaluate treatment outcomes and identify risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 1009 patients in the SEER database, TT was associated with multifocality (P\u2009 &amp;lt; \u2009.001) and local nodal metastasis (P\u2009 &amp;lt; \u2009.001). After PSM, 73 pairs were matched. In the Chinese cohort from Zhejiang Cancer Hospital, TT was correlated with larger tumor (P\u2009&amp;lt;\u2009.001), higher calcitonin peak-to-basal ratio (P\u2009 = \u2009.002), and T2 stage (P\u2009 = \u2009.025), with 38 matched pairs after PSM. Cox regression analyses showed that the extent of thyroid resection was not an independent prognostic factor for overall survival (SEER: OS P\u2009 = \u2009.607) or progression-free survival (Chinese cohort: PFS P\u2009 = \u2009.411). Kaplan-Meier analysis revealed no significant survival differences between the TT and lobectomy groups (SEER: OS P\u2009 = \u2009.43; Chinese cohort: PFS P\u2009 = \u2009.21). Additionally, the TT group had more frequent adverse events (transient hypocalcemia: P\u2009&amp;lt;\u2009.001, transient vocal cord paralysis: P\u2009&amp;lt;\u2009.025), longer hospital stays (P\u2009 = \u2009.011), and higher costs (P\u2009 = \u2009.001) than the lobectomy group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>For patients with early-stage MTC, lobectomy may be an optimal alternative option that does not impair prognosis and confers a low risk of adverse events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyaf250","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T18:31:21Z","timestamp":1755023481000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparison of lobectomy vs total thyroidectomy for medullary thyroid carcinoma: a SEER analysis with Chinese cohort validation"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2250-1264","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences , Hangzhou 310022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Records and Statistics, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences , Hangzhou 310022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Dan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences , Hangzhou 310022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences , Hangzhou 310022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9808-843X","authenticated-orcid":false,"given":"Ling-Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences , Hangzhou 310022,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"2025092107470279300_oyaf250-B1","first-page":"339","article-title":"Pregnancy and thyroid cancer: ultrasound study of foetal thyroid","volume":"29","author":"Zamperini","year":"2009","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2025092107470279300_oyaf250-B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/ec-18-0494","article-title":"Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study","volume":"8","author":"Mathiesen","year":"2019","journal-title":"Endocr Connect"},{"key":"2025092107470279300_oyaf250-B3","doi-asserted-by":"publisher","first-page":"107708","DOI":"10.1016\/j.pharmthera.2020.107708","article-title":"Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer","volume":"219","author":"Chiacchiarini","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2025092107470279300_oyaf250-B4","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3390\/cancers12113124","article-title":"Medullary thyroid cancer in patients older than 45-epidemiologic trends and predictors of survival","volume":"12","author":"Gogna","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025092107470279300_oyaf250-B5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2025092107470279300_oyaf250-B6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American thyroid association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"2025092107470279300_oyaf250-B7","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"key":"2025092107470279300_oyaf250-B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1245\/s10434-021-11077-9","article-title":"Medullary thyroid cancer: 60 years of gradual understanding","volume":"29","author":"Doherty","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2025092107470279300_oyaf250-B9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","article-title":"Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Haddad","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"2025092107470279300_oyaf250-B10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00268-008-9795-2","article-title":"Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution","volume":"33","author":"Ito","year":"2009","journal-title":"World J Surg"},{"key":"2025092107470279300_oyaf250-B11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00268-002-6665-1","article-title":"Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations","volume":"26","author":"Miyauchi","year":"2002","journal-title":"World J Surg"},{"key":"2025092107470279300_oyaf250-B12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/moo.0000000000000612","article-title":"Controversies in the surgical management of sporadic medullary thyroid carcinoma","volume":"28","author":"Fussey","year":"2020","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2025092107470279300_oyaf250-B13","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/sla.0000000000003580","article-title":"The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults","volume":"271","author":"Patel","year":"2020","journal-title":"Ann Surg"},{"key":"2025092107470279300_oyaf250-B14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1210\/jc.2013-2942","article-title":"The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer","volume":"99","author":"Esfandiari","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025092107470279300_oyaf250-B15","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1007\/s00268-018-4738-z","article-title":"Static prognostic factors and appropriate surgical designs for patients with medullary thyroid carcinoma: the second report from a single-institution study in Japan","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"key":"2025092107470279300_oyaf250-B16","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.surg.2022.06.023","article-title":"Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: a propensity-matched survival analysis","volume":"172","author":"Liang","year":"2022","journal-title":"Surgery"},{"key":"2025092107470279300_oyaf250-B17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/jso.24954","article-title":"Survival in patients with medullary thyroid cancer after less than the recommended initial operation","volume":"117","author":"Randle","year":"2018","journal-title":"J Surg Oncol"},{"key":"2025092107470279300_oyaf250-B18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1749-4486.2007.01536.x","article-title":"Risk factors for permanent laryngeal nerve paralysis in patients with thyroid carcinoma","volume":"32","author":"Sevim","year":"2007","journal-title":"Clin Otolaryngol"},{"key":"2025092107470279300_oyaf250-B19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.surg.2013.03.011","article-title":"Extent of thyroidectomy affects vocal and throat functions: a prospective observational study of lobectomy versus total thyroidectomy","volume":"154","author":"Ryu","year":"2013","journal-title":"Surgery"},{"key":"2025092107470279300_oyaf250-B20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jamcollsurg.2014.03.019","article-title":"Voice outcomes after total thyroidectomy, partial thyroidectomy, or non-neck surgery using a prospective multifactorial assessment","volume":"219","author":"Vicente","year":"2014","journal-title":"J Am Coll Surg"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyaf250\/63969687\/oyaf250.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/9\/oyaf250\/63969687\/oyaf250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/9\/oyaf250\/63969687\/oyaf250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T11:47:10Z","timestamp":1758455230000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyaf250\/8223481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf250","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,6]]},"article-number":"oyaf250"}}